IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q1 2021 Holdings

Filed 2021-05-14 | 54 holdings | $13.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Corcept Therapeutics Inc(CORT)COM218352102$1.2M50,0009.0%
Cullinan Oncology Inc(CGEM)COM230031106$2.5M60,11418.9%
Biogen Inc(BIIB)COM09062X103$3.4M12,10025.5%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$4.6M177,00034.4%
PreviousPage 2 of 2